NJ Judge Tailors Evidence In Novartis Bone Drug Mass Tort
Novartis Pharmaceutical Corp. on Friday was able to limit certain expert testimony for a Mississippi woman claiming its bone cancer drug Zometa caused osteonecrosis of her jaw, but a New Jersey...To view the full article, register now.
Already a subscriber? Click here to view full article